
Christina Cheddar Berk
Investing Trends Editor, Pro at CNBC
Editor, Investing Trends, CNBC Pro | @CNBC | Former @dowjones
Articles
-
4 weeks ago |
cnbc.com | Tanaya Macheel |Christina Cheddar Berk
A smartphone with the Coinbase logo and representation of cryptocurrencies are placed on a keyboard in this photo taken June 8, 2023. Dado Ruvic | ReutersCoinbase shares fell as first-quarter revenue came in shy of Wall Street's expectations, despite the growth in stablecoin revenue. In the quarter ended March 31, Coinbase earned $65.6 million, or 24 cents per share, down from $1.18 billion, or $4.40 a share a year ago.
-
1 month ago |
nbcchicago.com | Yun Li |Christina Cheddar Berk |Alex Harring
Berkshire Hathaway Chairman and CEO Warren Buffett will preside over the company's annual meeting. Track all of the day's news and analysis here. CNBC will be livestreaming the Berkshire Hathaway annual shareholder meeting on Saturday, beginning with a pre-show at 8:30 a.m. ET.
-
1 month ago |
cnbc.com | Yun Li |Christina Cheddar Berk |Alex Harring
CNBC will be livestreaming the Berkshire Hathaway annual shareholder meeting on Saturday, beginning with a pre-show at 8:30 a.m. ET. The annual gathering has long been known as "Woodstock for Capitalists." Each year the event draws Berkshire Hathaway shareholders from around the world to hear the latest thoughts and reflections from the 94-year-old Warren Buffett. This year's meeting takes place after the market has experienced a very volatile start to the year.
-
1 month ago |
cnbc.com | Christina Cheddar Berk
As investors try to find their footing after recent bouts of hyper-volatile trading, portfolio manager Dan Niles is cautioning patience. "You can't fix all your positioning problems in one day," the founder and portfolio manager at Niles Investment Management told CNBC's "Closing Bell Overtime" on Wednesday.
-
2 months ago |
cnbc.com | Christina Cheddar Berk
Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump's goal of bringing manufacturing back to the United States has put the industry in the administration's crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated the idea and hinted that details would arrive in early April.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 3K
- Tweets
- 3K
- DMs Open
- No